Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
GRI Bio Inc (NASDAQ: GRI) closed the day trading at $1.40 down -6.67% from the previous closing price of $1.50. In other words, the price has decreased by -$6.67 from its previous closing price. On the day, 0.73 million shares were traded.
Ratios:
For a better understanding of GRI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 09, 2024, initiated with a Buy rating and assigned the stock a target price of $10.
Stock Price History:
Over the past 52 weeks, GRI has reached a high of $106.04, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -54.40%, while the 200-Day Moving Average is calculated to be -83.85%.
Shares Statistics:
Insiders hold about 0.05% of the company’s shares, while institutions hold 0.25% stake in the company.
Earnings Estimates
GRI Bio Inc (GRI) is currently under the scrutiny of 2 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.62, with high estimates of -$0.18 and low estimates of -$1.05.
Analysts are recommending an EPS of between -$1.1 and -$5.15 for the fiscal current year, implying an average EPS of -$3.12. EPS for the following year is -$2.05, with 2.0 analysts recommending between -$0.51 and -$3.59.
